|Bid||38.84 x 1800|
|Ask||38.85 x 2900|
|Day's range||38.58 - 39.08|
|52-week range||33.26 - 42.68|
|Beta (5Y monthly)||0.38|
|PE ratio (TTM)||16.15|
|Earnings date||01 Feb 2017 - 06 Feb 2017|
|Forward dividend & yield||2.21 (5.65%)|
|Ex-dividend date||19 Aug 2021|
|1y target est||48.04|
Dr. James Simmons, Hospitalist Nurse Practitioner in Los Angeles, CA, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Dr. Susannah Hills, Pediatric Airway Surgeon and Assistant Professor of ENT at Columbia University Medical Center, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Comirnaty, the COVID-19 vaccine marketed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX), should rake in $33.5 billion in sales this year. Pfizer also claims the world's second best-selling vaccine. The company won U.S. regulatory approval for a successor product, Prevnar 20, in immunizing adults earlier this summer.